Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743644311> ?p ?o ?g. }
- W2743644311 endingPage "364" @default.
- W2743644311 startingPage "353" @default.
- W2743644311 abstract "In the mammalian central nervous system (CNS) GABAA receptors (GABAARs) mediate neuronal inhibition and are important therapeutic targets. GABAARs are composed of 5 subunits, drawn from 19 proteins, underpinning expression of 20–30 GABAAR subtypes. In the CNS these isoforms are heterogeneously expressed and exhibit distinct physiological and pharmacological properties. We report the discovery of S44819, a novel tricyclic oxazolo-2,3-benzodiazepine-derivative, that selectively inhibits α5-subunit-containing GABAARs (α5-GABAARs). Current α5-GABAAR inhibitors bind to the “benzodiazepine site”. However, in HEK293 cells expressing recombinant α5-GABAARs, S44819 had no effect on 3H-flumazenil binding, but displaced the GABAAR agonist 3H-muscimol and competitively inhibited the GABA-induced responses. Importantly, we reveal that the α5-subunit selectivity is uniquely governed by amino acid residues within the α-subunit F-loop, a region associated with GABA binding. In mouse hippocampal CA1 neurons, S44819 enhanced long-term potentiation (LTP), blocked a tonic current mediated by extrasynaptic α5-GABAARs, but had no effect on synaptic GABAARs. In mouse thalamic neurons, S44819 had no effect on the tonic current mediated by δ-GABAARs, or on synaptic (α1β2γ2) GABAARs. In rats, S44819 enhanced object recognition memory and reversed scopolamine-induced impairment of working memory in the eight-arm radial maze. In conclusion, S44819 is a first in class compound that uniquely acts as a potent, competitive, selective antagonist of recombinant and native α5-GABAARs. Consequently, S44819 enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy. Given this profile, S44819 may improve cognitive function in neurodegenerative disorders and facilitate post-stroke recovery." @default.
- W2743644311 created "2017-08-17" @default.
- W2743644311 creator A5006460217 @default.
- W2743644311 creator A5012636877 @default.
- W2743644311 creator A5015149435 @default.
- W2743644311 creator A5016414908 @default.
- W2743644311 creator A5017662410 @default.
- W2743644311 creator A5019556156 @default.
- W2743644311 creator A5021600405 @default.
- W2743644311 creator A5041054619 @default.
- W2743644311 creator A5046657472 @default.
- W2743644311 creator A5048175554 @default.
- W2743644311 creator A5050743339 @default.
- W2743644311 creator A5062195334 @default.
- W2743644311 creator A5073747881 @default.
- W2743644311 creator A5080135978 @default.
- W2743644311 creator A5082403586 @default.
- W2743644311 creator A5084058341 @default.
- W2743644311 creator A5088172807 @default.
- W2743644311 date "2017-10-01" @default.
- W2743644311 modified "2023-10-14" @default.
- W2743644311 title "Selective inhibition of extra-synaptic α5-GABA A receptors by S44819, a new therapeutic agent" @default.
- W2743644311 cites W1483960272 @default.
- W2743644311 cites W1524203275 @default.
- W2743644311 cites W1578372898 @default.
- W2743644311 cites W1590163747 @default.
- W2743644311 cites W1965234912 @default.
- W2743644311 cites W1965922846 @default.
- W2743644311 cites W1968685262 @default.
- W2743644311 cites W1977516874 @default.
- W2743644311 cites W1985097707 @default.
- W2743644311 cites W1998581169 @default.
- W2743644311 cites W2002734542 @default.
- W2743644311 cites W2015503015 @default.
- W2743644311 cites W2017160535 @default.
- W2743644311 cites W2017884282 @default.
- W2743644311 cites W2023382980 @default.
- W2743644311 cites W2025114609 @default.
- W2743644311 cites W2025812590 @default.
- W2743644311 cites W2032730889 @default.
- W2743644311 cites W2040717681 @default.
- W2743644311 cites W2041359982 @default.
- W2743644311 cites W2041454408 @default.
- W2743644311 cites W2043385322 @default.
- W2743644311 cites W2046987765 @default.
- W2743644311 cites W2050347923 @default.
- W2743644311 cites W2061659417 @default.
- W2743644311 cites W2062186332 @default.
- W2743644311 cites W2074990246 @default.
- W2743644311 cites W2080054063 @default.
- W2743644311 cites W2086350824 @default.
- W2743644311 cites W2088403966 @default.
- W2743644311 cites W2092802659 @default.
- W2743644311 cites W2099631417 @default.
- W2743644311 cites W2101446007 @default.
- W2743644311 cites W2109235361 @default.
- W2743644311 cites W2110151543 @default.
- W2743644311 cites W2112232226 @default.
- W2743644311 cites W2113042263 @default.
- W2743644311 cites W2118063127 @default.
- W2743644311 cites W2121438811 @default.
- W2743644311 cites W2128784337 @default.
- W2743644311 cites W2137471600 @default.
- W2743644311 cites W2138788537 @default.
- W2743644311 cites W2144531560 @default.
- W2743644311 cites W2154889134 @default.
- W2743644311 cites W2157081213 @default.
- W2743644311 cites W2157852024 @default.
- W2743644311 cites W2190422553 @default.
- W2743644311 cites W2209939627 @default.
- W2743644311 cites W2314890784 @default.
- W2743644311 cites W2338677800 @default.
- W2743644311 cites W2559815764 @default.
- W2743644311 cites W2583579329 @default.
- W2743644311 cites W2728608275 @default.
- W2743644311 cites W2911703946 @default.
- W2743644311 cites W759287092 @default.
- W2743644311 doi "https://doi.org/10.1016/j.neuropharm.2017.08.012" @default.
- W2743644311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28807671" @default.
- W2743644311 hasPublicationYear "2017" @default.
- W2743644311 type Work @default.
- W2743644311 sameAs 2743644311 @default.
- W2743644311 citedByCount "37" @default.
- W2743644311 countsByYear W27436443112016 @default.
- W2743644311 countsByYear W27436443112018 @default.
- W2743644311 countsByYear W27436443112019 @default.
- W2743644311 countsByYear W27436443112020 @default.
- W2743644311 countsByYear W27436443112021 @default.
- W2743644311 countsByYear W27436443112022 @default.
- W2743644311 countsByYear W27436443112023 @default.
- W2743644311 crossrefType "journal-article" @default.
- W2743644311 hasAuthorship W2743644311A5006460217 @default.
- W2743644311 hasAuthorship W2743644311A5012636877 @default.
- W2743644311 hasAuthorship W2743644311A5015149435 @default.
- W2743644311 hasAuthorship W2743644311A5016414908 @default.
- W2743644311 hasAuthorship W2743644311A5017662410 @default.
- W2743644311 hasAuthorship W2743644311A5019556156 @default.
- W2743644311 hasAuthorship W2743644311A5021600405 @default.